NANETS members connect with colleagues from across North America with a passionate concern for optimal delivery of comprehensive cancer diagnosis, treatment and management of patients with neuroendocrine tumor (NET) disease. NANETS offers a dynamic forum for developmental innovation and professional growth.*

Each NANETS member extends the reach and influence of our society. Our members broaden our capacity to educate providers, thereby exponentially increasing our ability to improve NET patient care. We welcome original perspectives and new ideas.

The insight and expertise of our members are the driving forces of our medical society. Additional benefits of membership include:

  • Reduced registration fees for the Annual Multidisciplinary NET Disease Symposium (CME accredited)
  • Online access to the NANETS affiliated medical journal, Endocrine-Related Cancer (ERC), paid for by NANETS
  • 25% discount on the full price charges for any color printing and supplementary data when their article is accepted for publication in ERC.
  • Ability to apply for NANETS research grants
  • Access to NANETS Grant Resources Portal, an online collective of research funding opportunities available for NET research
  • Access to NANETS member directory
  • Participation in NANETS' Committees
  • First to know about NANETS regional NET education CME programs
  • Opportunity to mentor with established experts in the field of neuroendocrine cancer
  • Opportunity to educate young professionals
  • Opportunity to apply for travel grants
  • First to know about professional medical opportunities throughout North America
  • Voting rights in elections

*Membership is non-transferrable and non-refundable.

Join NANETS Today! 

 

 

 

More about ERC

 

ENDOCRINE-RELATED CANCER

In early January NANETS announced that it entered into an agreement with Bioscientifica for publication of NANETS’ research work in its scientific journal, Endocrine Related Cancer (ERC), a premier global forum for basic, translational and clinical research on hormones and cancers, with over 40,000 unique users and a 5.678 impact factor.

ERC is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the Japanese Hormones and Cancer Society and the Endocrine Society of Australia.

Features Include:

  • Original articles covering new basic and clinical research
  • Reviews

[NANETS Member Access to Endocrine-Related Cancer online content is available via the this link: https://erc.bioscientifica.com/] – Only to be included in the text in the members' area.

In addition to online access to the journal, NANETS members also receive a 25% discount on publication charges (color printing and supplementary data) when their article is published in the journal.

Find out more about the journal and register to receive the latest content and news from ERC directly to your inbox via the journal website.

You can contact the ERC editorial team at This email address is being protected from spambots. You need JavaScript enabled to view it.